(Q41703323)

7 October 2017

Phorbol ester-induced enhancement in lytic activity of CD8+ splenic T cells from low-dose melphalan-treated MOPC-315-tumor bearers (English)

1 reference

7 October 2017

L M Weiskirch

1

1 reference

7 October 2017

B A Baumgartel

series ordinal

2

1 reference

7 October 2017

E Barker

series ordinal

3

1 reference

7 October 2017

M B Mokyr

series ordinal

4

1 reference

7 October 2017

1 January 1991

1 reference

Cancer Immunology, Immunotherapy

7 October 2017

1 reference

7 October 2017

32

1 reference

7 October 2017

6

1 reference

7 October 2017

353-363

1 reference

https://scigraph.springernature.com/pub.10.1007/bf01741330

7 October 2017

0 references

cites work

Importance of tumor-specific cytotoxic CD8+ T-cells in eradication of a large subcutaneous MOPC-315 tumor following low-dose melphalan therapy

1 reference

12 December 2020

Eradication of a large MOPC-315 tumor in athymic nude mice by chemoimmunotherapy with Lyt2+ splenic T cells from melphalan-treated BALB/c mice bearing a large MOPC-315 tumor

1 reference

12 December 2020

Modification of tumor regression by immunologic means

1 reference

12 December 2020

Melphalan-mediated potentiation of antitumor immune responsiveness of immunosuppressed spleen cells from mice bearing a large MOPC-315 tumor

1 reference

12 December 2020

Increase in the effectiveness of melphalan therapy with progression of MOPC-315 plasmacytoma tumor growth.

1 reference

12 December 2020

Tumor immunity to murine plasma cell tumors. I. Tumor-associated transplantation antigens of NZB and BALB-c plasma cell tumors

1 reference

12 December 2020

Specificity of the generation and expression of enhanced anti-plasmacytoma immunity by spleen cells from melphalan-treated MOPC-315 tumor bearers

1 reference

12 December 2020

IgG or IgM monoclonal antibodies reactive with different determinants on the molecular complex bearing Lyt 2 antigen block T cell-mediated cytolysis in the absence of complement

1 reference

12 December 2020

Requirements for triggering of lysis by cytolytic T lymphocyte clones

1 reference

12 December 2020

Importance of Lyt 2+ T-cells in the curative effectiveness of a low dose of melphalan for mice bearing a large MOPC-315 tumor

1 reference

12 December 2020

Therapy of the murine plasmacytoma MOPC 104E: role of the immune response

1 reference

12 December 2020

Oxazaphosphorines as biological response modifiers--experimental and clinical perspectives

1 reference

12 December 2020

Chemotherapy of mice bearing syngeneic tumors with 1,3-bis (2-chloroethyl)-1-nitrosourea is effective only in normal, but not in irradiated or nude, mice: role of L3T4+ (CD4+) and Lyt-2+ (CD8+) T cells

1 reference

12 December 2020

Effect of phorbol esters on alloimmune cytolysis

1 reference

12 December 2020

Antigen-receptor interaction requirement for conjugate formation and lethal-hit triggering by cytotoxic T lymphocytes can be bypassed by protein kinase C activators and Ca2+ ionophores

1 reference

12 December 2020

Effectiveness of Murine Leukemia Chemotherapy According to the Immune State: Reconsideration of Correlations Between Chemotherapy, Tumour Cell Killing, and Survival Time

1 reference

12 December 2020

Xenogeneic Monoclonal Antibodies to Mouse Lymphoid Differentiation Antigens*

1 reference

12 December 2020

Protein kinase C required for cytotoxic T lymphocyte triggering

1 reference

12 December 2020

Serine esterase in cytolytic T lymphocytes

1 reference

12 December 2020

Characterization of the murine T cell surface molecule, designated L3T4, identified by monoclonal antibody GK1.5: similarity of L3T4 to the human Leu-3/T4 molecule

1 reference

12 December 2020

Host immune potentiation of drug responses to a murine mammary adenocarcinoma

1 reference

12 December 2020

Cyclophosphamide-induced immunologically mediated regression of a cyclophosphamide-resistant murine tumor: a consequence of eliminating precursor L3T4+ suppressor T-cells.

1 reference

12 December 2020

Host-mediated therapeutic effects produced by appropriately timed administration of bleomycin on a rat fibrosarcoma

1 reference

12 December 2020

Protein kinase C (PKC) inhibitors inhibit primary (1-0) but not secondary (1-1) or cloned cytotoxic T lymphocytes

1 reference

12 December 2020

Phorbol-ester stimulated lysis of weak and nonspecific target cells by cytotoxic T lymphocytes

1 reference

12 December 2020

Role of antitumor immunity in cyclophosphamide-induced rejection of subcutaneous nonpalpable MOPC-315 tumors.

1 reference

12 December 2020

Immunomodulation by various nitrosoureas and its effect on the survival of the murine host bearing a syngeneic tumor.

1 reference

12 December 2020

Cooperation between cyclophosphamide tumoricidal activity and host antitumor immunity in the cure of mice bearing large MOPC-315 tumors

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01741330

1 reference

Dimensions Publication ID

7 October 2017

0 references

1 reference